Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding notice was added at the top of the page stating potential delays and that the NIH Clinical Center is open. The recruitment status indicator 'Active, not recruiting' was removed, and the page includes a revision notice (Revision: v3.4.1) with updated dates in January 2026.SummaryDifference0.9%

- Check28 days agoChange DetectedThe page adds a 'Show glossary' option and introduces QC-related labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check42 days agoChange Detected- Revision label updated from v3.3.3 to v3.3.4. No user-facing content changes were detected.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new Locations section with Surrey; removed the Surrey Locations block and the HHS Vulnerability Disclosure link as part of revision v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the Revision to v3.3.2. Deleted the older wording stating that PubMed publications come from PubMed and are automatically created by ClinicalTrials.gov with Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.